BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 17428106)

  • 1. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
    Nayak A; Langdon RB
    Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
    Philip G; Malmstrom K; Hampel FC; Weinstein SF; LaForce CF; Ratner PH; Malice MP; Reiss TF;
    Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S; Malice MP; Dass SB; Reiss TF
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of montelukast for treating perennial allergic rhinitis.
    Philip G; Williams-Herman D; Patel P; Weinstein SF; Alon A; Gilles L; Tozzi CA; Dass SB; Reiss TF
    Allergy Asthma Proc; 2007; 28(3):296-304. PubMed ID: 17619558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH; Howland WC; Arastu R; Philpot EE; Klein KC; Baidoo CA; Faris MA; Rickard KA
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG; Andrews CP; van Bavel JH; Hampel FC; Klein KC; Prillaman BA; Faris MA; Philpot EE
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):851-7. PubMed ID: 16802774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis].
    Lu Y; Yin M; Cheng L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Aug; 49(8):659-67. PubMed ID: 25351124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
    Esteitie R; deTineo M; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):155-61. PubMed ID: 20674827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P
    Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of montelukast in the treatment of asthma and allergic rhinitis.
    Nayak A
    Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
    Wilson AM; Orr LC; Coutie WJ; Sims EJ; Lipworth BJ
    Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B; Anolik R; Danzig M; Yao R
    Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
    Nathan RA; Yancey SW; Waitkus-Edwards K; Prillaman BA; Stauffer JL; Philpot E; Dorinsky PM; Nelson HS
    Chest; 2005 Oct; 128(4):1910-20. PubMed ID: 16236835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.